(Q35024658)

5 August 2017

1 reference

title

Opioid peptides and the control of human ingestive behaviour (English)

1 reference

5 August 2017

0 references

Martin R Yeomans

1

1 reference

PubMed ID

12479844

5 August 2017

Richard W Gray

series ordinal

2

1 reference

5 August 2017

1 October 2002

1 reference

Neuroscience & Biobehavioral Reviews

5 August 2017

1 reference

5 August 2017

26

1 reference

5 August 2017

713-728

1 reference

5 August 2017

6

1 reference

Suppression of appetitive behavior in the rat by naloxone: Lack of effect of prior morphine dependence

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Endogenous opioid peptides and regulation of drinking and feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Why do we eat? A neural systems approach

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Evidence for opiate receptor involvement in the consumption of a high palatability diet in nondeprived rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naltrexone suppresses hyperphagia induced in the rat by a highly palatable diet

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naloxone's anorectic effect is dependent upon the relative palatability of food

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Flavor enhances the antidipsogenic effect of naloxone.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naloxone suppresses intake of highly preferred saccharin solutions in food deprived and sated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Effects of opiate agonists and antagonists on fluid intake and saccharin choice in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Attenuation of sham feeding by naloxone is stereospecific: evidence for opioid mediation of orosensory reward

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Prior exposure to low or high fat milk enhances naloxone anorexia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Exposure to sweetened solutions enhances the anorectic effect of naloxone but not d-fenfluramine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Enhanced anorectic potency of naloxone in rats sham feeding 30% sucrose: reversal by repeated naloxone administration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Opiate receptor blockade in man reduces 2-deoxy-d-glucose-induced food intake but not hunger, thirst, and hypothermia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naloxone reduces the food intake of normal human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naloxone reduces food intake in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Taste responses and preferences for sweet high-fat foods: Evidence for opioid involvement☆

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Effects of aging on the opioid modulation of feeding in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Effects of a low dose of naltrexone on glucose-induced allesthesia and hunger in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Failure of naltrexone to affect the pleasantness or intake of food.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Selective effects of naltrexone on food pleasantness and intake.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Effects of naltrexone on food intake and changes in subjective appetite during eating: evidence for opioid involvement in the appetizer effect

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Effects of nalmefene on feeding in humans. Dissociation of hunger and palatability.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Lower pleasantness of palatable foods in nalmefene-treated human volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Adverse effects of oral naltrexone: analysis of data from two clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Increased fat consumption induced by morphine administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Hypothalamic injection of morphine: feeding and temperature responses

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Differential effects of morphine on food and water intake in food deprived and freely-feeding rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Ventral tegmental injections of a selective mu or delta opioid enhance feeding in food-deprived rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Morphine and morphine-6beta-glucuronide-induced feeding are differentially reduced by G-protein alpha-subunit antisense probes in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Amphetamine- and morphine-induced feeding: evidence for involvement of reward mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Intake of a palatable sucrose solution modifies the actions of spiradoline, a kappa opioid receptor agonist, on analgesia and feeding behavior in male and female rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Effects of kappa opiate agonists on palatable food consumption in non-deprived rats, with and without food preloads

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Effect of butorphanol tartrate on food and water consumption in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Butorphanol tartrate induces feeding in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Butorphanol increases food-reinforced operant responding in satiated rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

The effect of selective opioid antagonists on butorphanol-induced feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Identification of central sites involved in butorphanol-induced feeding in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

The controls of eating: a shift from nutritional homeostasis to behavioral neuroscience

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Uncoupling sweet taste and calories: comparison of the effects of glucose and three intense sweeteners on hunger and food intake.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Acquired sensory control of satiation in man

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Effects of equicaloric loads of protein, fat, and carbohydrate on food intake in the rat and man

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Effects of weight and energy content of preloads on subsequent appetite and food intake.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Relative contributions of intestinal, gastric, oro-sensory influences and information to changes in appetite induced by the same liquid meal

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Maltodextrin preloads reduce food intake without altering the appetiser effect.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Effects of test-meal palatability on compensatory eating following disguised fat and carbohydrate preloads

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Relative effects of carbohydrates and protein on satiety -- a review of methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

The effect of naltrexone on taste detection and recognition threshold.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Effects of the opioid remifentanil on olfactory function in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Opioid mediation of odor preferences induced by sugar and fat in 6-day-old rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Intracerebroventricular infusions of morphine, and blockade with naloxone, modify the olfactory preferences for pup odors in lactating rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Physiological Role of Pleasure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

The time course of sensory-specific satiety

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Pleasantness changes and food intake in a varied four-course meal

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Individual differences in the use of pleasantness and palatability ratings.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Sensory specific satiety in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Rating changes over the course of meals: what do they tell us about motivation to eat?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Palatability and the micro-structure of feeding in humans: the appetizer effect.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

The microstructure of ingestive behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Palatability-induced hyperphagia increases hypothalamic Dynorphin peptide and mRNA levels

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Effects of taste stimulation on beta-endorphin levels in rat cerebrospinal fluid and plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Hyperendorphinemia in obesity and relationships to affective state.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Hyperendorphinemia in obesity is not related to the affective state

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Palatability of a meal influences release of beta-endorphin, and of potential regulators of food intake in healthy human subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Lack of plasmic beta-endorphin response to a gastronomic meal in healthy humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Immunoreactive beta-endorphin increases after an aspartame chocolate drink in healthy human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naloxone decreases food intake in obese humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Effects of long-term therapy with naltrexone on body weight in obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

High-dose naltrexone therapy and dietary counseling for obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Single-dose naloxone acutely reduces eating in obese humans: behavioral and biochemical effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naltrexone and human eating behavior: a dose-ranging inpatient trial in moderately obese men.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Effect of naloxone on food consumption in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Opioid involvement in feeding behaviour and the pathogenesis of certain eating disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Characteristics of abnormal food-intake patterns in children with Prader-Willi syndrome and study of effects of naloxone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Effect of naloxone on hyperphagia in Prader-Willi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Effect of naltrexone on food intake, hunger, and satiety in obese men.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Cerebrospinal fluid opioid activity in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Clonidine stimulation in anorexia nervosa: growth hormone, cortisol, and beta-endorphin responses

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Are disturbances in opioid and adrenergic systems involved in the hormonal dysfunction of anorexia nervosa?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Stress-Induced Eating Is Mediated Through Endogenous Opiates

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

CSF beta-endorphin and dynorphin in bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Eating behavior and plasma beta-endorphin in bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Plasma immunoreactive beta-endorphin in bulimics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naltrexone reverses bulimic symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

The use of opiate antagonists in treating bulimia: a study of low-dose versus high-dose naltrexone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naloxone but not CCK-8 may attenuate binge-eating behavior in patients with the bulimia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Effect of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normoweight bulimic and obese, binge-eating subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Laboratory studies of eating behavior in women with bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Feeding patterns in bulimia nervosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Drinking, thirst and water intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naloxone attenuates drinking behavior in a schizophrenic patient displaying self-induced water intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Decreased polydipsia in schizophrenic patients treated with naloxone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Involvement of the endogenous opioid system in the drinking behavior of schizophrenic patients displaying self-induced water intoxication: a double-blind controlled study with naloxone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Treatment of psychogenic polydipsia: comparison of risperidone and olanzapine, and the effects of an adjunctive angiotensin-II receptor blocking drug (irbesartan)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naltrexone in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Six-month follow-up of naltrexone and psychotherapy for alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naltrexone for alcohol dependence: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naltrexone in the treatment of alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Neuropharmacological treatments for alcoholism: scientific basis and clinical findings

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Effect of naltrexone on alcohol "high" in alcoholics.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Non-specific effect of naltrexone on ethanol consumption in social drinkers.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naltrexone increases the latency to drink alcohol in social drinkers.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Behavioral responses to ethanol in light and moderate social drinkers following naltrexone pretreatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naltrexone does not attenuate the acute behavioral effects of ethanol or pentobarbital in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Meta-analysis of cue-reactivity in addiction research

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naltrexone and alcohol dependence. Role of subject compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naloxone nonselective suppression of drinking of ethanol, sucrose, saccharin, and water by rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naloxone decreases ethanol consumption within a free choice paradigm in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Opiate blockade inhibits saccharin intake and blocks normal preference acquisition.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naloxone effects on sucrose-motivated behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Measuring hedonic impact in animals and infants: microstructure of affective taste reactivity patterns.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Low doses of naltrexone reduce palatability and consumption of ethanol in outbred rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Reduction of alcohol drinking and upregulation of opioid receptors by oral naltrexone in AA rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Dietary compensation by humans for supplemental energy provided as ethanol or carbohydrate in fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Short-term effects of alcohol consumption on appetite and energy intake

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

The hyperphagic effect of a high-fat diet and alcohol intake persists after control for energy density.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Ethanol as an energy source in humans: comparison with dextrose-containing beverages

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Alcohol and the appetizer effect

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Failure to reduce short-term appetite following alcohol is independent of beliefs about the presence of alcohol.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Stimulation of appetite by alcohol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

The appetizing effect of an apéritif in overweight and normal-weight humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Mu opioid receptor gene variants: lack of association with alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

The opioid receptor system and alcoholism: a genetic perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Sugars, sweetness, and food intake

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Sugar and body weight regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Elevated and sustained desire for sweet taste in african-americans: a potential factor in the development of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Evidence of preference for a high-concentration sucrose solution in alcoholic men

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Sweet taste preference as a risk factor for alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900041-6

7 January 2021

10.1016/S0149-7634(02)00041-6

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12479844